{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T20:49:51Z","timestamp":1791838191101,"version":"4.3.4"},"reference-count":48,"publisher":"SAGE Publications","issue":"10","license":[{"start":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T00:00:00Z","timestamp":1749686400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Int J STD AIDS"],"published-print":{"date-parts":[[2025,9]]},"abstract":"<jats:p>This guideline provides evidence-based recommendations for the use of doxycycline post exposure prophylaxis (doxyPEP) for the prevention of syphilis. DoxyPEP should be part of a comprehensive approach to the prevention of STIs, along with condom use, appropriate HIV prevention interventions, vaccination, STI testing, treatment and management, and appropriate risk reduction advice and psychological interventions if indicated.<\/jats:p>","DOI":"10.1177\/09564624251352053","type":"journal-article","created":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T15:02:22Z","timestamp":1749740542000},"page":"756-764","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":40,"title":["British Association for Sexual Health and HIV (BASHH) UK national guideline for the use of doxycycline post-exposure prophylaxis (DoxyPEP) for the prevention of syphilis, 2025"],"prefix":"10.1177","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3020-9916","authenticated-orcid":false,"given":"John","family":"Saunders","sequence":"first","affiliation":[{"name":"Blood Safety, Hepatitis, STIs and HIV Division, UK Health Security Agency, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Deering","sequence":"additional","affiliation":[{"name":"HCRG Care Group, Runcorn, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Dewsnap","sequence":"additional","affiliation":[{"name":"Sheffield Teaching Hospital Foundation Trust, Sheffield, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Drayton","sequence":"additional","affiliation":[{"name":"Department of sexual health, Cardiff and Vale University Health Board, Cardiff, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Gilmore","sequence":"additional","affiliation":[{"name":"School of Nursing, Midwifery and Health Systems, University College Dublin, Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"Grant","sequence":"additional","affiliation":[{"name":"Guy\u2019s &amp; St Thomas\u2019 NHS Foundation Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dwayne-Wilson","family":"Hunt","sequence":"additional","affiliation":[{"name":"Chelsea and Westminster NHS Foundation Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7247-1678","authenticated-orcid":false,"given":"Manik","family":"Kohli","sequence":"additional","affiliation":[{"name":"Institute for Global Health, University College London, London, UK"},{"name":"Mortimer Market Centre, Central and North West London NHS Foundation Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona","family":"Lyons","sequence":"additional","affiliation":[{"name":"National Clinical Lead, HSE Sexual Health Programme, Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamish","family":"Mohammed","sequence":"additional","affiliation":[{"name":"Blood Safety, Hepatitis, STIs and HIV Division, UK Health Security Agency, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phil","family":"Samba","sequence":"additional","affiliation":[{"name":"The Love Tank CIC, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Weil","sequence":"additional","affiliation":[{"name":"The Love Tank CIC, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"White","sequence":"additional","affiliation":[{"name":"Departments of GUM\/HIV Medicine, Londonderry, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Medland","sequence":"additional","affiliation":[{"name":"Kirby Institute, University of New South Wales, Sydney, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7756-403X","authenticated-orcid":false,"given":"Helen","family":"Fifer","sequence":"additional","affiliation":[{"name":"Blood Safety, Hepatitis, STIs and HIV Division, UK Health Security Agency, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2025,6,12]]},"reference":[{"key":"e_1_3_5_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(17)30725-9"},{"key":"e_1_3_5_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(24)00236-6"},{"key":"e_1_3_5_4_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2211934"},{"key":"e_1_3_5_5_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2304007"},{"key":"e_1_3_5_6_2","doi-asserted-by":"publisher","DOI":"10.1136\/sextrans-2024-056208"},{"key":"e_1_3_5_7_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa1832"},{"key":"e_1_3_5_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/s1473-3099(25)00085-4"},{"key":"e_1_3_5_9_2","unstructured":"Scott H Roman J Spinelli MA et al. Doxycycline PEP: high uptake and significant decline in STIs after clinical implementation. In: Conference on retrovirsuses and opportunistic infections (CROI) 2024."},{"key":"e_1_3_5_10_2","unstructured":"Sankaran M Glidden DV Kohn RP et al. Doxy-PEP associated with declines in Chlamydia and Syphilis in MSM and trans women in San Francisco. In: Conference on retrovirsuses and opportunistic infections (CROI) 2024."},{"key":"e_1_3_5_11_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2024.7186"},{"key":"e_1_3_5_12_2","doi-asserted-by":"publisher","DOI":"10.1089\/apc.2023.0289"},{"key":"e_1_3_5_13_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.326.7390.613"},{"key":"e_1_3_5_14_2","unstructured":"Doxycycline 100 mg capsules - the summary of product characteristics and the patient information leaflet. Sovereign Medical. Last updated 20 June 2024. Available from: https:\/\/www.medicines.org.uk\/emc\/product\/13082\/pil#about-medicine"},{"key":"e_1_3_5_15_2","doi-asserted-by":"publisher","DOI":"10.1097\/OLQ.0000000000001865"},{"key":"e_1_3_5_16_2","volume-title":"Bronchiectasis (non-cystic fibrosis), acute exacerbation: antimicrobial prescribing. NICE guideline [NG117]","author":"National Institute for Health and Care Excellence","year":"2018","unstructured":"National Institute for Health and Care Excellence. Bronchiectasis (non-cystic fibrosis), acute exacerbation: antimicrobial prescribing. NICE guideline [NG117]. London: NICE, 2018. [cited 2025 April 3]. Available from: https:\/\/www.nice.org.uk\/guidance\/ng117 (accessed 3 April 2025)."},{"key":"e_1_3_5_17_2","volume-title":"Acne vulgaris: management. NICE guideline [NG198]","author":"National Institute for Health and Care Excellence","year":"2023","unstructured":"National Institute for Health and Care Excellence. Acne vulgaris: management. NICE guideline [NG198]. London: NICE, 2023. [cited 2025 April 3]. Available from: https:\/\/www.nice.org.uk\/guidance\/ng198 (accessed 3 April 2025)."},{"key":"e_1_3_5_18_2","volume-title":"Urinary tract infection (recurrent): antimicrobial prescribing. NICE guideline [NG112]","author":"National Institute for Health and Care Excellence","year":"2024","unstructured":"National Institute for Health and Care Excellence. Urinary tract infection (recurrent): antimicrobial prescribing. NICE guideline [NG112]. London: NICE, 2024. [cited 2025 April 3]. Available from: https:\/\/www.nice.org.uk\/guidance\/ng112"},{"key":"e_1_3_5_19_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiae381"},{"key":"e_1_3_5_20_2","volume-title":"DoxyPEP and antimicrobial resistance in N. gonorrhoeae, commensal Neisseria and S. aureus. CROI 2023","author":"Luetkemeyer A","year":"2023","unstructured":"Luetkemeyer A, Donnell D, Dombrowski JC, et al. DoxyPEP and antimicrobial resistance in N. gonorrhoeae, commensal Neisseria and S. aureus. CROI 2023. Washington: Seattle, 2023."},{"key":"e_1_3_5_21_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaf089"},{"key":"e_1_3_5_22_2","doi-asserted-by":"publisher","DOI":"10.1097\/OLQ.0000000000001810"},{"key":"e_1_3_5_23_2","doi-asserted-by":"publisher","DOI":"10.1177\/09564624231190108"},{"key":"e_1_3_5_24_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-024-01023-3"},{"key":"e_1_3_5_25_2","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics12010145"},{"key":"e_1_3_5_26_2","doi-asserted-by":"publisher","DOI":"10.1089\/mdr.2021.0319"},{"key":"e_1_3_5_27_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1346-8138.2012.01626.x"},{"key":"e_1_3_5_28_2","doi-asserted-by":"publisher","DOI":"10.47102\/annals-acadmedsg.V30N1p22"},{"key":"e_1_3_5_29_2","doi-asserted-by":"publisher","DOI":"10.1093\/jtm\/taab028"},{"key":"e_1_3_5_30_2","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.1990.43.608"},{"key":"e_1_3_5_31_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-13-68"},{"key":"e_1_3_5_32_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid1303.060729"},{"key":"e_1_3_5_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2016.07.014"},{"key":"e_1_3_5_34_2","unstructured":"Burgener AD Grennan T Knodel S et al. DoxyPEP impact on the microbiome of men who have sex with men and transgender women on HIV PrEP. In: CROI 2025 San Francisco California 2025."},{"key":"e_1_3_5_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2024.106243"},{"key":"e_1_3_5_36_2","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2021.1900995"},{"key":"e_1_3_5_37_2","doi-asserted-by":"publisher","DOI":"10.1093\/jtm\/taad027"},{"key":"e_1_3_5_38_2","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens10081063"},{"key":"e_1_3_5_39_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2672.2008.03792.x"},{"key":"e_1_3_5_40_2","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abd8077"},{"key":"e_1_3_5_41_2","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9010168"},{"key":"e_1_3_5_42_2","doi-asserted-by":"publisher","DOI":"10.1002\/alr.22799"},{"key":"e_1_3_5_43_2","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9010185"},{"key":"e_1_3_5_44_2","volume-title":"GRASP report: data to August 2024","author":"Sun S","year":"2024","unstructured":"Sun S, Narayanan P, Vickers A, et al. GRASP report: data to August 2024. London: UK Health Security Agency, 2024."},{"key":"e_1_3_5_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2024.105037"},{"key":"e_1_3_5_46_2","unstructured":"Grant A. BASHH position statement on doxycycline use in pregnancy. 2024."},{"key":"e_1_3_5_47_2","volume-title":"Doxycycline 100mg capsules - summary of product characteristics (SmPC)","author":"Electronic Medicines Compendium","year":"2021","unstructured":"Electronic Medicines Compendium. Doxycycline 100mg capsules - summary of product characteristics (SmPC). UK: Datapharm. [cited 2025 April 3]. Available from: https:\/\/www.medicines.org.uk\/emc\/product\/13082\/smpc (2021, accessed 3 April 2025)."},{"key":"e_1_3_5_48_2","unstructured":"Drugs and Lactation Database (LactMed). Doxycycline. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK500561\/#:\u223c:text=Anumberofreviewshave (thrush%2Cdiaperrash)2024"},{"key":"e_1_3_5_49_2","doi-asserted-by":"publisher","DOI":"10.1136\/sextrans-2024-056240"}],"container-title":["International Journal of STD &amp; AIDS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/09564624251352053","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/09564624251352053","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/09564624251352053","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T22:46:47Z","timestamp":1777675607000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/09564624251352053"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,12]]},"references-count":48,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["10.1177\/09564624251352053"],"URL":"https:\/\/doi.org\/10.1177\/09564624251352053","relation":{},"ISSN":["0956-4624","1758-1052"],"issn-type":[{"value":"0956-4624","type":"print"},{"value":"1758-1052","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,12]]}}}